Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,986 | -3,484 | 109,625 | 21,072 | 16,898 |
| Depreciation Amortization | 13,212 | 6,631 | 33,700 | 25,161 | 16,911 |
| Income taxes - deferred | -1,385 | -1,367 | -80,375 | N/A | N/A |
| Accounts receivable | 3,749 | -1,109 | -996 | -319 | -4,176 |
| Other Working Capital | -862 | -1,666 | -13,014 | -7,121 | 2,127 |
| Other Operating Activity | 21,618 | 23,712 | 29,658 | 13,108 | 10,096 |
| Operating Cash Flow | $41,318 | $22,717 | $78,598 | $51,901 | $41,856 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -528 | N/A | -274 | N/A | N/A |
| Net Acquisitions | -280 | -105 | -42,399 | -16,889 | -16,518 |
| Investing Cash Flow | $-808 | $-105 | $-42,673 | $-16,889 | $-16,518 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 70,000 | 65,916 | N/A |
| Debt Repayment | -10,500 | -10,500 | -70,750 | -70,750 | -11,750 |
| Common Stock Issued | 157 | N/A | 7,020 | 7,020 | 7,020 |
| Other Financing Activity | -24,933 | -8,450 | -14,064 | -9,182 | -5,154 |
| Financing Cash Flow | $-35,276 | $-18,950 | $-7,794 | $-6,996 | $-9,884 |
| Beginning Cash Position | 64,941 | 64,941 | 36,810 | 36,810 | 36,810 |
| End Cash Position | 70,175 | 68,603 | 64,941 | 64,826 | 52,264 |
| Net Cash Flow | $5,234 | $3,662 | $28,131 | $28,016 | $15,454 |
| Free Cash Flow | |||||
| Operating Cash Flow | 41,318 | 22,717 | 78,598 | 51,901 | 41,856 |
| Capital Expenditure | -528 | N/A | -274 | 0 | 0 |
| Free Cash Flow | 40,790 | 22,717 | 78,324 | 51,901 | 41,856 |